Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/0267659120979887 http://scihub22266oqcxt.onion/10.1177/0267659120979887 33280533!ä!33280533 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Perfusion 2021 ; 36 (6): 575-581 Nephropedia Template TP {{tp|p=33280533|t=2021. Adequate anticoagulation and ECMO therapy in COVID-19 patients with severe pulmonary embolism |pdf=|usr=}}{{33280533}} gab.com Text Adequate anticoagulation and ECMO therapy in COVID-19 patients with severe pulmonary embolism JO: Perfusion http://www.kidney.de/pget.php?&tw=1&pmid=33280533 #FOAvip SARS-CoV-2 (COVID-19) infections have been recently shown to be associated with a high rate of thromboembolic events due to pro-coagulative mechanisms that have not yet been fully understood. This paper reports on a 55-year-old female COVID-19 patient with severe ARDS and pulmonary embolism (PE) complicated by cardiogenic shock after 12 days of hospitalization under initial prophylactic anticoagulation with low molecular weight heparin (LMWH). An ultima-ratio va (veno-arterial) ECMO implantation and subsequent rapid upgrade to vvaECMO due to insufficient oxygenation was performed. The patient developed severe coagulopathy with intrapulmonary bleeding. The present report aims to highlight and discuss the pros and cons of various anticoagulation strategies in COVID-19 patients focusing on current scientific debates to address this frequently observed complication in the current situation worldwide. Twit Text FOAVip Adequate anticoagulation and ECMO therapy in COVID-19 patients with severe pulmonary embolism ????Perfusion http://www.kidney.de/pget.php?&tw=1&pmid=33280533 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33280533 #FOAvip English Wikipedia <ref>{{Cite pmid|33280533}}</ref> Adequate anticoagulation and ECMO therapy in COVID-19 patients with severe pulmonary embolism #MMPMID33280533 Gaisendrees C; Walter SG; Elderia A; Vollmer M; Kaya S; Djordjevic I; Eghbalzadeh K; Sabashnikov A; Kahlert HA; Deppe AC; Boll B; Madershahian N; Wahlers T Perfusion 2021[Sep]; 36 (6): 575-581 PMID33280533show ga SARS-CoV-2 (COVID-19) infections have been recently shown to be associated with a high rate of thromboembolic events due to pro-coagulative mechanisms that have not yet been fully understood. This paper reports on a 55-year-old female COVID-19 patient with severe ARDS and pulmonary embolism (PE) complicated by cardiogenic shock after 12 days of hospitalization under initial prophylactic anticoagulation with low molecular weight heparin (LMWH). An ultima-ratio va (veno-arterial) ECMO implantation and subsequent rapid upgrade to vvaECMO due to insufficient oxygenation was performed. The patient developed severe coagulopathy with intrapulmonary bleeding. The present report aims to highlight and discuss the pros and cons of various anticoagulation strategies in COVID-19 patients focusing on current scientific debates to address this frequently observed complication in the current situation worldwide. |*COVID-19[MESH] |*Extracorporeal Membrane Oxygenation[MESH] |*Pulmonary Embolism/complications[MESH] |Anticoagulants/therapeutic use[MESH] |Female[MESH] |Heparin, Low-Molecular-Weight[MESH] |Humans[MESH] |Middle Aged[MESH]Adequate anticoagulation and ECMO therapy in COVID-19 patients with se(epmc).pdf DeepDyve Pubget Overpricing